Case Studies
Client Situation
In order to plan and efficiently utilize their sales and marketing efforts, a mid-sized biopharma client wanted to identify HCPs likely to adopt their drug in the early stage of launch
Trinity’s Role
Developed an Early Adopter Identification Engine to predict which prescribers were likely to adopt the drug in the initial launch stage
Collaborated with internal stakeholders and downstream partners for seamless execution
Created a customizable dashboard for HCP profiling, targeting prioritization and sales pattern identification
Identified…
Read Now
Webinars
May 14, 2024 | 1:00 - 1:45 PM ET
Predictive insights on stakeholder behavior are crucial, whether for demand assessments, segmentation, message testing, market mapping or ATUs—and the more rooted in reality these predictions are, the more confidence in the estimates and outputs. Join Trinity Insights experts Clive Mendonca, Managing Director & Head of Quantitative Insights and Amod Athavale, Director & Head of Integrated Insights as they lead a lively discussion of the applications and benefits of using integrated insights from PMR and real-world evidence (RWE).
Key Webinar Topics…
Sign Up Now
Case Studies
Client Situation
A large biopharma customer wanted to develop a dynamic targeting solution for HCPs in a particular market
Trinity’s Role
Using machine learning, Trinity developed a model to predict HCPs’ future prescribing engagement
Segmented prescribers into targeting tiers, updated on a quarterly basis
Prioritized the prescriber tiers
Project Outcomes
Trinity delivered a model with 84% accuracy.*
The solution supports a new, agile approach to call planning and execution to achieve better engagement using advanced analytics to dynamically target HCPs…
Read Now
Case Studies
Client Situation
As part of an enterprise-wide Digital Transformation initiative, our client was looking to optimize effectiveness of marketing execution channels—and maximize clinical and commercial outcomes—by personalizing campaigns through engaging HCPs with the most relevant content (safety, efficacy, support, etc.)
The client was first looking to scale an existing brand-specific NBA solution across all their inline brands. However, there were several challenges with the initial application and this approach:
Basic, limited functionality with no prediction capability around sequential touchpoints
High…
Read Now
Blog
Published March 20, 2024
Executive Summary
The Italian Medicines Agency (AIFA) underwent transformative changes on January 30, 2024, following a much-anticipated reorganization. AIFA’s restructuring has already faced challenges, with the recent resignation of the newly created Scientific and Economic Commission’s (CSE) chairman followed by the appointment of a new acting chairman, highlighting the need for a stable and collaborative leadership within AIFA.
Although AIFA’s overhaul has been implemented following a year-long delay due to bureaucratic complexities and is currently facing uncertainties, it will be…
Read Now
Case Studies
Client Situation
A midsize biopharma client wanted to create a rep-centric tool to help them understand their targets and map against current performance and gaps, identify changes in market scenario, manage schedules, prioritize targets and deliver contextual content
Trinity’s Role
Trinity developed a comprehensive field force tool to track target treatment paradigms, analyze market drivers and identify Next Best Actions (NBAs)
Integrated tightly with rep calendars to provide triggers with insights and recommendations contextual to rep schedules
Leveraged multiple data…
Read Now
Webinars
Available On Demand
Trinity Life Sciences is pleased to release our highly anticipated white paper, the Annual State of Global Market Access. This year’s white paper focuses on six key global market access trends and provides payer perspectives on these trends. We explore the consequences of new therapeutic advances and policies aiming to control costs globally and the impacts for pharma manufacturers.
Register for this webinar for a deeper dive into a few trends in the white paper. Join experts from our Evidence,…
Watch Now
Case Studies
Client Situation
A large biopharma customer wanted to optimize their digital channel strategy and outreach to most effectively engage with HCPs
Trinity’s Role
Trinity developed an AI solution that predicts the next best digital channel, content and cadence to engage with individual HCPs
Although originally created for one brand, the technology and AI model was crafted so that it could be scaled and easily configured to add different criteria and datasets
After success with the initial brand, Trinity expanded the…
Read Now
White Papers
In 2023, the life sciences industry saw key therapeutic advances in sickle cell disease, obesity/weight management, and Duchenne muscular dystrophy, among others, and the continued approvals of therapies with cutting edge mechanisms, including the first CRISPR therapy. While 2022 was characterized by accelerated development processes and the rapid evolution of therapeutic standards, 2023 featured increased implementation of cost-effectiveness policies and the emergence of the consequences of these pricing controls and cost-effectiveness measures, including the Inflation Reduction Act (IRA) and Germany’s…
Read Now
Blog
Published February 26, 2024
Executive Summary
Multiple cost-containment reforms, such as the introduction of a 20% rebate on brand-brand combinations and a temporary increase in the mandatory rebate on drugs to 12%, were implemented under Germany’s ‘Financial Stabilization of Statutory Health Insurance System’ Act (GKV-Finanzstabilisierungsgesetz) in 2023. The evaluation report of these strategies showed that the actual savings for the year fell short of the proposed target (25% deficit, €1.4 Bn vs. target of €1.9 Bn) for all such reforms except 30% higher savings…
Read Now
